Publishing research using ab58227? Please let us know so that we can cite the reference in this datasheet.

ab58227 has been referenced in 3 publications.

  • Tan HL  et al. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas. Mod Pathol N/A:N/A (2014). PubMed: 25216229
  • Cathomas R  et al. Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07). Clin Cancer Res 18:6049-6057 (2012). IHC-P ; Human . PubMed: 22977195
  • Lamontagne J  et al. Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis. J Virol 84:907-17 (2010). WB ; Human . PubMed: 19864383

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"